angiotensin ii has been researched along with Torsade de Pointes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coker, SJ; Dempster, J; Farkas, A | 1 |
| Leunissen, JD; Londoño, C; Ramakers, C; Schoenmakers, M; van Opstal, JM; Vos, MA | 1 |
2 other study(ies) available for angiotensin ii and Torsade de Pointes
| Article | Year |
|---|---|
Importance of vagally mediated bradycardia for the induction of torsade de pointes in an in vivo model.
Topics: Action Potentials; Adrenergic alpha-Agonists; Angiotensin II; Animals; Anti-Arrhythmia Agents; Blood Pressure; Bradycardia; Carbon Dioxide; Disease Models, Animal; Electrocardiography; Heart; Heart Rate; Hydrogen-Ion Concentration; Male; Oxygen; Phenylephrine; Potassium; Quaternary Ammonium Compounds; Rabbits; Reflex; Time Factors; Torsades de Pointes; Vagotomy; Vagus Nerve | 2008 |
Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Bradycardia; Chymases; Dose-Response Relationship, Drug; Female; Heart Block; Humans; Hypertrophy, Left Ventricular; Irbesartan; Male; Peptidyl-Dipeptidase A; Phenethylamines; Potassium Channel Blockers; Serine Endopeptidases; Sulfonamides; Tetrazoles; Torsades de Pointes | 2003 |